GLP1R and diabetes mellitus: However, it must be noted that SGLT2i and GLP-1 RA are very effective inreducing cardiovascular risk, which steadily burdens patients with diabetes at least as muchas COVID-19 during the pandemic, thus their benefit justifies their continued use.